Cargando…
Cancer Pain Assessment and Classification
More than half of patients affected by cancer experience pain of moderate-to-severe intensity, often in multiple sites, and of different etiologies and underlying mechanisms. The heterogeneity of pain mechanisms is expressed with the fluctuating nature of cancer pain intensity and clinical character...
Autores principales: | Caraceni, Augusto, Shkodra, Morena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521068/ https://www.ncbi.nlm.nih.gov/pubmed/30974857 http://dx.doi.org/10.3390/cancers11040510 |
Ejemplares similares
-
Treatment of Neuropathic Pain Directly Due to Cancer: An Update
por: Shkodra, Morena, et al.
Publicado: (2022) -
Neuropathic pain: clinical classification and assessment in patients with pain due to cancer
por: Shkodra, Morena, et al.
Publicado: (2021) -
Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment
por: Shkodra, Morena, et al.
Publicado: (2022) -
A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab
por: Bracchi, Paola, et al.
Publicado: (2023) -
Telemedicine for outpatient palliative care during COVID-19 pandemics: a longitudinal study
por: Caraceni, Augusto, et al.
Publicado: (2022)